Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ribosome-inactivating proteins: progress and problems.

F Stirpe1, M G Battelli

  • 1Dipartimento di Patologia sperimentale, Alma Mater Studiorum Università di Bologna, Via S. Giacomo 14, 40126, Bologna, Italy. fiorenzo.stirpe@unibo.it

Cellular and Molecular Life Sciences : CMLS
|June 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discrepancy between clinical and radiological responses in non-infectious pneumonia during immunotherapy: a case report.

European review for medical and pharmacological sciences·2025
Same author

Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6.

Journal of biological regulators and homeostatic agents·2012
Same author

Increased serum level of xanthine oxidoreductase in liver transplanted patients.

Journal of biological regulators and homeostatic agents·2011
Same author

Toxicity of xanthine oxidoreductase to malignant B lymphocytes.

Journal of biological regulators and homeostatic agents·2006
Same author

CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia.

Journal of biological regulators and homeostatic agents·2006
Same author

Occupational sensitization to ribosome-inactivating proteins in researchers.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2005

Ribosome-inactivating proteins (RIPs) depurinate rRNA, inhibiting protein synthesis and causing cell damage. These versatile enzymes show potential in agriculture and medicine, particularly in antiviral therapies and targeted cancer treatment via immunotoxins.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Toxicology

Background:

  • Ribosome-inactivating proteins (RIPs), primarily plant-derived enzymes, function by depurinating rRNA, thereby inhibiting cellular protein synthesis.
  • Beyond rRNA, RIPs can modify other polynucleotide substrates, indicating broader enzymatic activity.
  • The complete biological role and mechanisms of RIPs, including functions independent of protein synthesis inhibition, are still under investigation.

Purpose of the Study:

  • To explore the diverse biological activities and cytotoxic effects of Ribosome-inactivating proteins (RIPs).
  • To review the potential applications of RIPs in agriculture and medicine, focusing on their antiviral properties and use in immunotoxins.
  • To highlight the current understanding and future prospects regarding the distribution, action mechanisms, and natural roles of RIPs.

Related Experiment Videos

Main Methods:

  • Literature review and synthesis of existing research on Ribosome-inactivating proteins (RIPs).
  • Analysis of reported cytotoxic and toxicological data for various RIPs.
  • Examination of studies detailing the antiviral activities and immunotoxin applications of RIPs.

Main Results:

  • RIPs exhibit varying cytotoxicity and toxicity, with some, like ricin, recognized as potent toxins.
  • RIPs induce cellular damage through apoptotic and necrotic pathways and stimulate cytokine production, leading to inflammation.
  • Identified potential applications include agricultural uses and medical therapies, such as antiviral treatments and targeted cancer therapies using immunotoxins.

Conclusions:

  • Ribosome-inactivating proteins (RIPs) possess significant enzymatic and cytotoxic properties with diverse biological implications.
  • Their dual nature as potential toxins and therapeutic agents underscores the need for further research.
  • Future developments are anticipated in understanding RIPs' roles and expanding their applications in medicine and agriculture.